GHTF Should Harmonize Emerging Areas of Device Regulation, EU Reps Say
This article was originally published in The Gray Sheet
Executive Summary
The Global Harmonization Task Force should review new medical technology areas before countries develop separate regulatory practices for them, EUCOMED Director-General Michael Baker asserted at the Annual GHTF Conference in Ottawa, Canada Sept. 18-22.
You may also be interested in...
European Commission To Review Tissue Products Draft Directive In December
Eucomed is optimistic that European Union member states will adopt a proposed directive on tissue-engineered products, but the trade association notes that implementation probably will not occur before 2005
European Commission To Review Tissue Products Draft Directive In December
Eucomed is optimistic that European Union member states will adopt a proposed directive on tissue-engineered products, but the trade association notes that implementation probably will not occur before 2005
Emerging Technology Poses Chief Strategic Challenge For GHTF
Members of the Global Harmonization Task Force will be tasked with defining processes for identifying crucial scientific and regulatory issues involving select examples of new and emerging medical technologies